 Kintara Therapeutics Inc NASDAQ: KTRA shares are trading higher by 28.6 to 0.24 after the FDA granted Fast Track Designation to the companys VAL-083. Fast Track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an. 